Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg versus other long-acting reversible contraceptives for contraception in Spain

  1. Conde, J.C.Q.
  2. Parra Ribes, I.
  3. Perelló-Capo, J.
  4. Lobo Abascal, P.
  5. García, I.C.
  6. Andeyro García, M.
  7. Gutiérrez Alés, J.
  8. Herrero Conde, M.
  9. Rius Tarruella, J.
  10. Espinós Lafuente, B.
Revue:
European Journal of Contraception and Reproductive Health Care

ISSN: 1473-0782 1362-5187

Année de publication: 2024

Type: Article

DOI: 10.1080/13625187.2024.2369843 GOOGLE SCHOLAR